These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29603600)

  • 21. Deacetylase inhibitor trichostatin A down-regulates Foxp3 expression and reduces CD4+CD25+ regulatory T cells.
    Liu Z; Zhang C; Sun J
    Biochem Biophys Res Commun; 2010 Sep; 400(3):409-12. PubMed ID: 20801101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichostatin A promotes the generation and suppressive functions of regulatory T cells.
    Doñas C; Fritz M; Manríquez V; Tejón G; Bono MR; Loyola A; Rosemblatt M
    Clin Dev Immunol; 2013; 2013():679804. PubMed ID: 23737814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors.
    Sugimoto K; Itoh T; Takita M; Shimoda M; Chujo D; SoRelle JA; Naziruddin B; Levy MF; Shimada M; Matsumoto S
    Transpl Int; 2014 Apr; 27(4):408-15. PubMed ID: 24410777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance.
    Wang L; Tao R; Hancock WW
    Immunol Cell Biol; 2009; 87(3):195-202. PubMed ID: 19172156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.
    Wang L; Liu Y; Han R; Beier UH; Bhatti TR; Akimova T; Greene MI; Hiebert SW; Hancock WW
    J Clin Invest; 2015 Mar; 125(3):1111-23. PubMed ID: 25642770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells.
    Kwon HS; Lim HW; Wu J; Schnölzer M; Verdin E; Ott M
    J Immunol; 2012 Mar; 188(6):2712-21. PubMed ID: 22312127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase.
    Fayyad-Kazan H; Rouas R; Merimi M; El Zein N; Lewalle P; Jebbawi F; Mourtada M; Badran H; Ezzeddine M; Salaun B; Romero P; Burny A; Martiat P; Badran B
    J Biol Chem; 2010 Jul; 285(27):20481-91. PubMed ID: 20427269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deacetylase inhibition promotes the generation and function of regulatory T cells.
    Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
    Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.
    Saouaf SJ; Li B; Zhang G; Shen Y; Furuuchi N; Hancock WW; Greene MI
    Exp Mol Pathol; 2009 Oct; 87(2):99-104. PubMed ID: 19577564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function.
    Xiao Y; Li B; Zhou Z; Hancock WW; Zhang H; Greene MI
    Curr Opin Immunol; 2010 Oct; 22(5):583-91. PubMed ID: 20869864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of Foxp3 induction and maintenance by sequential histone acetylation and DNA demethylation.
    Li J; Xu B; He M; Zong X; Cunningham T; Sha C; Fan Y; Cross R; Hanna JH; Feng Y
    Cell Rep; 2021 Dec; 37(11):110124. PubMed ID: 34910919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications.
    Dong Y; Yang C; Pan F
    Front Immunol; 2021; 12():626172. PubMed ID: 33912156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The attenuation of renal fibrosis by histone deacetylase inhibitors is associated with the plasticity of FOXP3
    Wu WP; Tsai YG; Lin TY; Wu MJ; Lin CY
    BMC Nephrol; 2017 Jul; 18(1):225. PubMed ID: 28693431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two lysines in the forkhead domain of foxp3 are key to T regulatory cell function.
    Liu Y; Wang L; Han R; Beier UH; Hancock WW
    PLoS One; 2012; 7(1):e29035. PubMed ID: 22247766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo.
    Glauben R; Sonnenberg E; Wetzel M; Mascagni P; Siegmund B
    J Biol Chem; 2014 Feb; 289(9):6142-51. PubMed ID: 24421314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor.
    Zeng YQ; Liu XS; Wu S; Zou C; Xie Q; Xu SM; Jin XW; Li W; Zhou A; Dai Z
    Am J Transplant; 2015 Jul; 15(7):1782-92. PubMed ID: 25808405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers.
    Du T; Nagai Y; Xiao Y; Greene MI; Zhang H
    Exp Mol Pathol; 2013 Aug; 95(1):38-45. PubMed ID: 23644046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC10 deletion promotes Foxp3
    Dahiya S; Beier UH; Wang L; Han R; Jiao J; Akimova T; Angelin A; Wallace DC; Hancock WW
    Sci Rep; 2020 Jan; 10(1):424. PubMed ID: 31949209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival.
    Beier UH; Wang L; Bhatti TR; Liu Y; Han R; Ge G; Hancock WW
    Mol Cell Biol; 2011 Mar; 31(5):1022-9. PubMed ID: 21199917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.